Lara E Graves, David J Torpy, P Toby Coates, Ian E Alexander, Stefan R Bornstein, Brigette Clarke
doi : 10.1210/clinem/dgac751
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1273–1289
Primary adrenal insufficiency (PAI) occurs in 1 in 5 to 7000 adults. Leading etiologies are autoimmune adrenalitis in adults and congenital adrenal hyperplasia (CAH) in children. Oral replacement of cortisol is lifesaving, but poor quality of life, repeated adrenal crises, and dosing uncertainty related to lack of a validated biomarker for glucocorticoid sufficiency persists.
Hans Olav Ueland, Arve Ulvik, Kristian Løvås, Anette S B Wolff, Lars Ertesvåg Breivik, Ann-Elin Meling Stokland, Eyvind Rødahl, Roy Miodini Nilsen, Eystein Husebye, Grethe Åstrøm Ueland
doi : 10.1210/clinem/dgad004
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1290–1297
Graves disease (GD) is one of the most common autoimmune disorders. Recent literature has shown an immune response involving several different inflammatory related proteins in these patients.
Daniele Cappellani, Giulia Marconcini, Luca Manetti, Luigi Bartalena, Fausto Bogazzi
doi : 10.1210/clinem/dgac756
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1298–1307
Patients with amiodarone-induced thyrotoxicosis (AIT) often receive initial therapy for thyrotoxicosis in several different medical settings before admission to a referral center.
Eloi Gagnon, Patricia L Mitchell, Benoit J Arsenault
doi : 10.1210/clinem/dgac758
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1308–1317
Hyperinsulinemia and adiposity are associated with one another, but the directionality of this relation is debated.
Wenbo Jiang, Jia Zhang, Ruiming Yang, Xinyi Sun, Huanyu Wu, Jiacheng Zhang, Siyao Liu, Changhao Sun, Lifang Ma, Tianshu Han, Wei Wei
doi : 10.1210/clinem/dgac741
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1318–1329
The hyperglycemia condition disrupts metabolism of nitrate/nitrite and nitric oxide, and dietary nitrate intake can restore nitric oxide homeostasis.
Xin Zhang, Jie-Rui Liu, Zhuan-Zhuan Mu, Xin-Qi Cheng, Yan-Song Lin
doi : 10.1210/clinem/dgac745
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1330–1337
Using response to surgery when tailoring radioiodine (RAI) therapy for papillary thyroid cancer (PTC) is valued but lacks prospective validation.
Hee Seung Lee, Wonjeong Chae, Min Je Sung, Jiyoung Keum, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Eun-Cheol Park, Chung Mo Nam, Sung-In Jang, Seungmin Bang
doi : 10.1210/clinem/dgac728
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1338–1347
Considering the absence of methods to find pancreatic cancer early, surveillance of high-risk groups is needed for early diagnosis.
Ching-Ti Liu, Timothy Tsai, Brett T Allaire, Mary L Bouxsein, Marian T Hannan, Thomas G Travison, Douglas P Kiel
doi : 10.1210/clinem/dgac744
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1348–1354
Visceral adipose tissue (VAT) has been recognized to be a metabolically active fat depot that may have paracrine effects on surrounding tissues, including muscle. Since many adults accumulate VAT as they age, the effect of changes in VAT on muscle is of interest.
Claudio Giacomozzi, Ayelen Martin, MarÃa Celia Fernández, Mariana Gutiérrez, Maria Iascone, Horacio M Domené, Fernando P Dominici, Ignacio Bergadá, Biagio Cangiano, Luca Persani, Patricia A Pennisi
doi : 10.1210/clinem/dgac738
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1355–1369
Insulin-like growth factor (IGF)1 gene mutations are extremely rare causes of pre- and postnatal growth retardation. Phenotype can be heterogenous with varying degrees of neurosensory deafness, cognitive defects, glucose metabolism impairment and short stature.
Jin Seok Lee, Jun Sung Lee, Hyeok Jun Yun, Seok Mo Kim, Hojin Chang, Yong Sang Lee, Hang-Seok Chang, Cheong Soo Park
doi : 10.1210/clinem/dgac739
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1370–1375
Tumor size is important in determining the range of surgery in papillary thyroid carcinomas (PTCs), especially those smaller than 1 cm.
Alfonso Galderisi, Carmella Evans-Molina, Mariangela Martino, Sonia Caprio, Claudio Cobelli, Antoinette Moran
doi : 10.1210/clinem/dgac740
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1376–1386
The oral minimal model is a widely accepted noninvasive tool to quantify both β-cell responsiveness and insulin sensitivity (SI) from glucose, C-peptide, and insulin concentrations during a 3-hour 9-point oral glucose tolerance test (OGTT).
Adrian Post, Wendy A Dam, Sara Sokooti, Dion Groothof, Jolein Gloerich, Alain J van Gool, Daan Kremer, Ron T Gansevoort, Jacob van den Born, Ido P Kema, Casper F M Franssen, Robin P F Dullaart, Stephan J L Bakker
doi : 10.1210/clinem/dgac729
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1387–1393
Fibroblast growth factor 21 (FGF21) is a peptide hormone synthesized by several organs and regulates, among others, energy homeostasis. In obesity, insulin resistance and type 2 diabetes (T2D), higher circulating FGF21 concentrations have been found.
Chang Liu, Meng Wang, Haixia Yao, Mengge Cui, Xueqi Gong, Lan Wang, Cong Sui, Hanwang Zhang
doi : 10.1210/clinem/dgac733
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1394–1404
Polycystic ovary syndrome (PCOS) is one of the most common diseases that contribute to subfertility. Recent evidence showed that oocytes of women with PCOS matured in vitro away from the follicular fluid presented better potentials, whereas the reason remained unclear.
Hajime Kato, Rena Okawa, Toru Ogasawara, Yoshitomo Hoshino, Naoko Hidaka, Minae Koga, Yuka Kinoshita, Hiroshi Kobayashi, Yuki Taniguchi, Seiji Fukumoto, Masaomi Nangaku, Noriko Makita, Kazuto Hoshi, Kazuhiko Nakano, Nobuaki Ito
doi : 10.1210/clinem/dgac732
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1405–1414
Conventional treatment of X-linked hypophosphatemia (XLH) was reported to prevent dental complications, but whether the preventive effect was different among different types of teeth, including anterior teeth and molar teeth, is uncertain. Evidence of the preventive effect of conventional treatment on ectopic ossifications is also limited.
Xiao Yang, Jiali Zhou, Huige Shao, Bi Huang, Xincong Kang, Ruiyu Wu, Fangzhou Bian, Minghai Hu, Dongbo Liu
doi : 10.1210/clinem/dgac661
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1415–1424
The 2021 consensus report on the definition and interpretation of remission of type 2 diabetes (T2D) has been released. Although intermittent fasting diets (IF) are becoming very popular, no studies have investigated their benefit in diabetes remission.
Saloni U Lad, Khawla F Ali, Philip C Johnston, Vicente T San Martin, Rita Bottino, Yu Kuei Lin, R Matthew Walsh, Tyler Stevens, Chao Tu, Betul Hatipoglu
doi : 10.1210/clinem/dgac674
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1425–1431
Total pancreatectomy with islet autotransplantation (TPIAT) is a definitive management for intractable pain in patients with chronic pancreatitis (CP). Islet autotransplantation (IAT) allows for the preservation of beta cells to prevent complications of long-term diabetes.
Ruixin He, Ruizhi Zheng, Jie Zheng, Mian Li, Tiange Wang, Zhiyun Zhao, Shuangyuan Wang, Hong Lin, Jieli Lu, Yuhong Chen, Yu Xu, Weiqing Wang, Min Xu, Yufang Bi, Guang Ning
doi : 10.1210/clinem/dgac707
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1432–1441
Observational studies indicated obesity and glutamatergic dysfunction as potential risk factors of depression, and reported disturbance of glutamine metabolism in obese state. However, it remains unclear whether the interrelationships between obesity, glutamine, and depression are causal.
Manel Adi, Faegheh Ghanbari, Mallory L Downie, Adriana Hung, Cassiane Robinson-Cohen, Despoina Manousaki
doi : 10.1210/clinem/dgac724
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1442–1451
Observational studies investigating the role of vitamin D in renal function have yielded inconsistent results.
Rui M PatrÃcio da Silva-Júnior, Ana Carolina Bueno, Clarissa Silva Martins, Fernanda Coelli-Lacchini, Jorge Guilherme Okanobo Ozaki, Danillo Cunha de Almeida-e-Silva, Junier Marrero-Gutiérrez, Antônio Carlos dos Santos, Carlos Garcia-Peral, Hélio Rubens Machado, Marcelo Volpon dos Santos, Paula Lamparelli Elias, Ayrton C Moreira, Leandro M Colli, Ricardo Z N Vêncio, Sonir R Antonini, Margaret de Castro
doi : 10.1210/clinem/dgac703
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1452–1463
To explore pituitary tumors by methylome and transcriptome signatures in a heterogeneous ethnic population.
Aline Faccioli Bodoni, Fernanda Borchers Coeli-Lacchini, Juliana Lourenço Gebenlian, Lays Martin Sobral, Cristiana Bernadelli Garcia, Wilson Araújo Silva, Jr, Kamila Chagas Peronni, Leandra Náira Zambelli Ramalho, Fernando Silva Ramalho, Ayrton C Moreira, Margaret de Castro, Andreia Machado Leopoldino, Sonir Roberto Rauber Antonini
doi : 10.1210/clinem/dgac705
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1464–1474
Nicotinamide nucleotide transhydrogenase (NNT) acts as an antioxidant defense mechanism. NNT mutations cause familial glucocorticoid deficiency (FGD). How impaired oxidative stress disrupts adrenal steroidogenesis remains poorly understood.
Alexandre Dormoy, Magalie Haissaguerre, Géraldine Vitellius, Christine Do Cao, Aurore Geslot, Delphine Drui, Hélène Lasolle, Oceana Vieira-Pinto, Sylvie Salenave, Maud François, Marie Puerto, Hélène Du Boullay, Anne Mayer, Anne Rod, Claire Laurent, Philippe Chanson, Yves Reznik, Frédéric Castinetti, Olivier Chabre, Eric Baudin, Gérald Raverot, Antoine Tabarin, Jacques Young
doi : 10.1210/clinem/dgac691
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1475–1487
Prospective studies have demonstrated the efficacy of osilodrostat in Cushing disease. No study has evaluated osilodrostat in a series of patients with paraneoplastic Cushing syndrome/ectopic adrenocorticotropin syndrome (PNCS/EAS).
Liza Das, Pinaki Dutta
doi : 10.1210/clinem/dgac747
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1488–1504
Hypopituitarism, which refers to insufficiency of one or more hormones of the pituitary, can be due to myriad causes. The clinical and radiological spectrum of the condition is heterogeneous, based on the patient’s age, gender, clinical setting, and/or other past medical history.
Natasha M Appelman-Dijkstra, Stefan Pilz
doi : 10.1210/clinem/dgac734
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1505–1513
Taking care of patients with parathyroid disorders during pregnancy requires consideration of the physiological fundamental changes in bone and mineral metabolism occurring in these women. Diagnostic and therapeutic procedures regarding primary hyperparathyroidism (PHPT) and hypoparathyroidism significantly differ from the nonpregnant population.
Jordan J Wright, Douglas B Johnson
doi : 10.1210/clinem/dgac689
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1514–1525
Immune checkpoint inhibitors (ICI) are cancer therapies that are approved for use in at least 19 different cancers. They function by stimulating immune cell responses against cancer, and their toxicities comprise a host of autoinflammatory syndromes that may impact any organ system.
Christian E Nasr, Massimiliano Andrioli, Mayumi Endo, R Mack Harrell, Masha J Livhits, Ibitoro Osakwe, Preethi Polavarapu, Allan Siperstein, Shuanzeng Wei, Xingyu Zheng, Ruochen Jiang, Yangyang Hao, J I ng Huang, Joshua P Klopper, Richard T Kloos, Giulia Kennedy, Trevor E Angell
doi : 10.1210/clinem/dgac688
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages 1526–1532
The Afirma® GSC aids in risk stratifying indeterminate thyroid nodule cytology (ITN). The 2018 GSC validation study (VS) reported a sensitivity (SN) of 91%, specificity (SP) of 68%, positive predictive value (PPV) of 47%, and negative predictive value (NPV) of 96%. Since then, 13 independent real-world (RW) postvalidation studies have been published.
Althaf K Majeed, Swayamjeet Satapathy, Sanjana Ballal, Chandrasekhar Bal
doi : 10.1210/clinem/dgac731
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e208–e215
The American Thyroid Association (ATA) guidelines recommend Dynamic Risk Stratification (DRS) for predicting long-term outcomes and personalizing management in adult differentiated thyroid cancers (DTCs). However, its applicability in pediatric DTCs needs to be validated.
Tingting Geng, Jun-Xiang Chen, Yan-Feng Zhou, Qi Lu, Zhenzhen Wan, Liegang Liu, An Pan, Gang Liu
doi : 10.1210/clinem/dgac750
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e216–e222
Proton pump inhibitors (PPIs) are widely used drugs for gastric acid–related diseases and may affect the gut microbiome.
Hanseul Kim, Chen Yuan, Long H Nguyen, Kimmie Ng, Edward L Giovannucci
doi : 10.1210/clinem/dgac742
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e223–e229
Lower 25-hydroxyvitamin D (25(OH)D) levels have consistently been associated with higher mortality among participants with colorectal cancer (CRC).
Atieh Amouzegar, Mohammadjavad Honarvar, Safdar Masoumi, Maryam Tohidi, Ladan Mehran, Fereidoun Azizi
doi : 10.1210/clinem/dgac735
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e230–e239
The evidence suggest that insulin resistance (IR) complicates chronic kidney disease (CKD); however, the longitudinal association of IR with development of CKD is unknown.
Natasha Anouschka Müller, Nina Kaegi-Braun, Mirsada Durmisi, Carla Gressies, Pascal Tribolet, Zeno Stanga, Beat Mueller, Philipp Schuetz
doi : 10.1210/clinem/dgac743
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e240–e248
During illness, deiodination of thyroxine (T4) to triiodothyronine (T3) is downregulated. This is called “low T3 syndrome�, an adaptive metabolic mechanism to reduce energy expenditure and prevent catabolism.
Jiahui Wang, Wei Zhou, Zhiyi Song, Tianxiang Ni, Qian Zhang, Zi-Jiang Chen, Junhao Yan
doi : 10.1210/clinem/dgac726
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e249–e257
Some studies have reported the early miscarriage rate is higher in polycystic ovary syndrome (PCOS) women. However, there is a lack of evidence as to whether the risk of embryo abnormalities increases in PCOS women.
Matthew D Ettleson, Wesley H Prieto, Pedro S T Russo, Jose de Sa, Wen Wan, Neda Laiteerapong, Rui M B Maciel, Antonio C Bianco
doi : 10.1210/clinem/dgac725
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e258–e266
Small adjustments in levothyroxine (LT4) dose do not appear to provide clinical benefit despite changes in thyrotropin (TSH) levels within the reference range. We hypothesize that the accompanying changes in serum total triiodothyronine (T3) levels do not reflect the magnitude of the changes in serum TSH.
Evert F S van Velsen, Robin P Peeters, Merel T Stegenga, Folkert J van Kemenade, Tessa M van Ginhoven, Mathé van Balkum, Frederik A Verburg, W Edward Visser
doi : 10.1210/clinem/dgac721
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e267–e274
Many countries have national guidelines for the management of differentiated thyroid cancer (DTC), including a risk stratification system to predict recurrence of disease. Studies whether these guidelines could also have relevance, beyond their original design, in predicting survival are lacking.
Serdar Sahin, Tugce Sudutan, Yasin Kavla, Emre Durcan, Yeliz Yagiz Özogul, Burc Cagri Poyraz, Muge Sayitoglu, Hande Mefkure Ozkaya, Pinar Kadioglu
doi : 10.1210/clinem/dgac718
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e275–e282
Dopamine agonist (DA)–induced impulse control disorder (ICD) represents a group of behavioral disorders that are increasingly recognized in patients with prolactinoma.
Miaomiao Wang, Xin Chen, Wenjing Cui, Xinru Wang, Nandong Hu, Hongye Tang, Chao Zhang, Jirong Shen, Chao Xie, Xiao Chen
doi : 10.1210/clinem/dgac722
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e283–e294
Fractures are a serious consequence of osteoporosis in older adults. However, few longitudinal studies have shown the role of computed tomography (CT)-based radiomics in predicting osteoporotic fractures.
Morgana Mongraw-Chaffin, Ashley Hogan Tjaden, Austin Lyles Seals, Kristen Miller, Naheed Ahmed, Mark A Espeland, Michael Gibbs, Dorey Thomas, Diane Uschner, William S Weintraub, Sharon L Edelstein, Covid-19 Community Research Partnership
doi : 10.1210/clinem/dgac715
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e295–e305
Obesity and diabetes are established risk factors for severe SARS-CoV-2 outcomes, but less is known about their impact on susceptibility to COVID-19 infection and general symptom severity.
Elena Flowers, Bradley E Aouizerat, Alka M Kanaya, Jose C Florez, Xingyue Gong, Li Zhang
doi : 10.1210/clinem/dgac714
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e306–e312
MicroRNAs (miRs) are short (ie, 18-26 nucleotide) regulatory elements of messenger RNA translation to amino acids.
Trasias Mukama, Theron Johnson, Verena Katzke, Rudolf Kaaks
doi : 10.1210/clinem/dgac716
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e313–e325
The relationship between dehydroepiandrosterone sulfate (DHEAS) and mortality is of scientific and public health interest, yet it remains poorly understood.
Yanyan Qi, Shuang Chen, Heng Chen, Yang Chen, Yun Shi, Yao Qin, Mei Zhang, Tao Yang, Yong Gu
doi : 10.1210/clinem/dgac720
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e326–e333
Single positive islet autoantibodies (IAbs), sometimes detected in healthy individuals and patients with low-risk of developing type 1 diabetes (T1D), are considered to be irrelevant to the development of diabetes, making it difficult to diagnose and classify adult-onset diabetes.
Michael P Bancks, James Lovato, Ashok Balasubramanyam, Mace Coday, Karen C Johnson, Medha Munshi, Candida Rebello, Lynne E Wagenknecht, Mark A Espeland
doi : 10.1210/clinem/dgac706
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e334–e342
Type 2 diabetes is a risk factor for incident dementia but whether risk and treatment/prevention strategies differ by diabetes subgroup is unknown.
Seda Grigoryan, Winnie Nhan, Lei Zhang, Caitlin Urban, Lili Zhao, Adina F Turcu
doi : 10.1210/clinem/dgac701
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e343–e349
Pheochromocytomas and paragangliomas (PPGL) are rare causes of secondary hypertension, but when unrecognized, they can lead to serious complications. Data regarding PPGL screening are lacking.
Peter Igaz
doi : 10.1210/clinem/dgad029
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e350–e351
James G Boyle, Michael E J Lean
doi : 10.1210/clinem/dgac755
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e352–e353
Manuel André Virú-Loza, Ruth Elizabeth Chávez-Nomberto
doi : 10.1210/clinem/dgad054
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e354–e355
Mohamad Maghnie, Michael B Ranke, Mitchell E Geffner, Elpis Vlachopapadopoulou, Lourdes Ibáñez, Martin Carlsson, Wayne Cutfield, Raoul Rooman, Roy Gomez, Michael P Wajnrajch, Agnès Linglart, Renata Stawerska, Peter E Clayton, Feyza Darendeliler, Anita C S Hokken-Koelega, Reiko Horikawa, Toshiaki Tanaka, Helmuth-Günther Dörr, Kerstin Albertsson-Wikland, Michel Polak, Adda Grimberg
doi : 10.1210/clinem/dgad055
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Pages e356–e357,
doi : 10.1210/clinem/dgad167
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Page e358
doi : 10.1210/clinem/dgad067
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 6, June 2023, Page e359
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟